JUN 11, 2018 02:47 PM PDT

An Atlas of the Proteins in Human Blood

WRITTEN BY: Carmen Leitch

From our genes, our body makes proteins, which help make tissues and other structures, and carry out many cellular functions necessary for life. Now a team of researchers has created a genetic map of human proteins. The aim is to connect the proteins in our blood, called the blood proteome, with associated genes. This atlas is freely available online for researchers, hopefully, to advance the study of human health and disease. The work has been reported in the journal Nature.

"Compared to genes, proteins have been relatively understudied in human blood, even though they are the 'effectors' of human biology, are disrupted in many diseases, and are the targets of most medicines," noted the senior author, Dr. Adam Butterworth of the Department of Public Health and Primary Care at the University of Cambridge. "Novel technologies are now allowing us to start addressing this gap in our knowledge."

It had been challenging to measure proteins in blood, which made it difficult to know the origin and function of those proteins. Using a technique called SOMAscan (which is described in the video), this work has now linked around 2,000 genes with nearly 1,500 proteins. 

Proteins were measured in blood that had been collected from 3,300 individuals; then the researchers used the DNA from those participants to connect regions of their genomes with protein levels.

This atlas can guide disease researchers to biological pathways that are relevant to illness. In their report, the researchers were able to find the pathways that are involved in eczema and Crohn’s disease, for example.

"Thanks to the genomics revolution over the past decade, we've been good at finding statistical associations between the genome and disease, but the difficulty has been then identifying the disease-causing genes and pathways," said author Dr. James Peters. "Now, by combining our database with what we know about associations between genetic variants and disease, we are able to say a lot more about the biology of disease."

Image credit: Max Pixel

It was found that several variations of a gene could be influencing the level of one protein. The scientists gave each protein a score based on the gene variations that could impact its levels; that revealed new connections between proteins and disorders. In one example, a protein associated with lung disease, MMP12, was discovered to also link to heart disease. High levels of MMP12 have been connected to lower lung disease risk, but for heart disease and stroke, the opposite is true. That information could be essential to drug developers.

This work could be instrumental in drug development. It provides new information about how proteins are associated with disease.

"Our database is really just a starting point," added first author Benjamin Sun, from the Department of Public Health and Primary Care. "We've given some examples in this study of how it might be used, but now it's over to the research community to begin using it and finding new applications."

"Although our DNA provides our individual blueprint, it is the variations in the structure, function and amount of the proteins encoded by our genes which determine our susceptibility to disease and our response to medicines,” said Professor Metin Avkiran, Associate Medical Director at the British Heart Foundation. “This study provides exciting new insight into how proteins in the blood are controlled by our genetic make-up and opens up opportunities for developing new treatments for heart and circulatory disease."


Sources: AAAS/Eurekalert! via University of Cambridge, Nature

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 06, 2018
Cannabis Sciences
DEC 06, 2018
Targeting CB1 Receptors With Antibodies
A recent press release from the pharmaceutical company Integral Molecular, written by Kate Kadash-Edmondson, has demonstrated the safety of a new ther...
DEC 08, 2018
DEC 08, 2018
Atrial Fibrillation, Explained
Atrial fibrillation (A-Fib) is a term you've likely heard before. You may have even been told you live with A-Fib. What exactly is this common type of...
DEC 20, 2018
Cell & Molecular Biology
DEC 20, 2018
Identifying Molecular Markers of Aging
As people get older, some remain healthy while others begin to get chronically ill....
DEC 21, 2018
DEC 21, 2018
How the Gut Microbiome Controls the Intestinal Immune System
The gut microbiome has many important functions, including helping us digest food. But it has to protect itself from the immune system....
JAN 05, 2019
Health & Medicine
JAN 05, 2019
The CRISPR Craze - New Frontiers in Gene Editing
The CRISPR/Cas system is an adaptive prokaryotic immune system which allows bacteria to inhibit viral infection. In 2012, Jennifer Doudna and Emmanuelle Charpentier were...
JAN 07, 2019
Cell & Molecular Biology
JAN 07, 2019
Researchers Develop an Experimental Therapy for Triple-negative Breast Cancer
Between 12 and 17% of all breast cancer cases are triple-negative, a highly aggressive type with few therapeutic options....
Loading Comments...